血浆IL-8与TGF-β1水平预测非小细胞肺癌放射性肺毒性:一项验证研究
本研究在142例I-III期接受根治性放疗的非小细胞肺癌患者中,验证既往由平均肺剂量(MLD)联合白介素-8(IL-8)和转化生长因子-β1(TGF-β1)构成的放射性肺毒性(RILT)预测模型,并探索更多细胞因子的新模型。65例新患者验证显示,MLD联合放疗前IL-8及TGF-β1 2周/放疗前比值将预测RILT2的AUC从单用MLD的0.61提升至0.73;全部142例中该联合模型AUC从0.62提升至0.76。
要点
- 放疗前IL-8较低与TGF-β1 2周/放疗前比值较高与RILT2风险升高相关。
- MLD联合放疗前IL-8及TGF-β1 2周/放疗前比值可提高RILT2预测准确性。
- 在30种细胞因子中仅IL-8和TGF-β1与RILT2风险显著相关。
核心结论
- 验证了平均肺剂量联合放疗前IL-8水平及TGF-β1 2周/放疗前比值较单用MLD能更准确预测RILT2风险。
研究设计与样本
- 纳入142例I-III期接受根治性放疗的非小细胞肺癌患者,其中65例新患者用于验证既往发现,全部142例用于探索新模型。
- 在放疗前、放疗中2周和4周测量30种血浆炎症细胞因子,主要终点为≥2级放射性肺炎或症状性肺纤维化。
主要发现
- 验证队列中MLD联合放疗前IL-8及TGF-β1 2周/放疗前比值预测RILT的AUC为0.73,单用MLD为0.61。
- 全部142例中29例(20.4%)发生≥2级RILT,30种细胞因子中仅IL-8和TGF-β1与RILT2风险显著相关。
- 全部142例中MLD联合放疗前IL-8及TGF-β1 2周/放疗前比值预测RILT的AUC为0.76,单用MLD为0.62。
临床怎么用
- 对于接受根治性放疗的非小细胞肺癌患者,可考虑检测放疗前血浆IL-8及放疗2周时TGF-β1与放疗前比值,联合MLD用于RILT风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE AND OBJECTIVES: We previously reported that the combination of mean lung dose (MLD) and inflammatory cytokines interleukin-8 (IL-8) and transforming growth factor-β1 (TGF-β1) may provide a more accurate model for radiation-induced lung toxicity (RILT) prediction in 58 patients with non-small cell lung cancer (NSCLC). This study is to validate the previous findings with new patients and to explore new models with more cytokines. METHODS AND MATERIALS: One hundred forty-two patients with stage I-III NSCLC treated with definitive radiation therapy (RT) from prospective studies were included. Sixty-five new patients were used to validate previous findings, and all 142 patients were used to explore new models. Thirty inflammatory cytokines were measured in plasma samples before RT and 2 weeks and 4 weeks during RT (pre, 2w, 4w). Grade ≥2 RILT was defined as grade 2, and higher radiation pneumonitis or symptomatic pulmonary fibrosis was the primary endpoint. Logistic regression was performed to evaluate the risk factors of RILT. The area under the curve (AUC) for the receiver operating characteristic curves was used for model assessment. RESULTS: Sixteen of 65 patients (24.6%) experienced RILT2. Lower pre IL-8 and higher TGF-β1 2w/pre ratio were associated with higher risk of RILT2. The AUC increased to 0.73 by combining MLD, pre IL-8, and TGF-β1 2w/pre ratio compared with 0.61 by MLD alone to predict RILT. In all 142 patients, 29 patients (20.4%) experienced grade ≥2 RILT. Among the 30 cytokines measured, only IL-8 and TGF-β1 were significantly associated with the risk of RILT2. MLD, pre IL-8 level, and TGF-β1 2w/pre ratio were included in the final predictive model. The AUC increased to 0.76 by combining MLD, pre IL-8, and TGF-β1 2w/pre ratio compared with 0.62 by MLD alone. CONCLUSIONS: We validated that a combination of mean lung dose, pre IL-8 level, and TGF-β1 2w/pre ratio provided a more accurate model to predict the risk of RILT2 compared with MLD alone.
引用
- Wang S, Campbell J, Stenmark MH, et al. Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study. Int J Radiat Oncol Biol Phys. 2017. PMID: 28581403. doi:10.1016/j.ijrobp.2017.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。